The impact of HMG-CoA reductase inhibitors use on the clinical outcomes in critically ill patients with COVID-19: A multicenter, cohort study

K Al Sulaiman, O Aljuhani, GB Korayem… - Frontiers in Public …, 2022 - frontiersin.org
Background The cardiovascular complications of Coronavirus Disease 2019 (COVID-19) may
be attributed to the hyperinflammatory state leading to increased mortality in patients with …

[PDF][PDF] KRAS G12C-Mutant Non-Small-Cell Lung Adenocarcinoma: First Documented Report in the Arabian Gulf

AS Alsulaiman, SB Alharthi, AS Albariqi… - Cureus, 2022 - cureus.com
We report the first documented case series of two lung adenocarcinoma patients demonstrating
Kirsten rat sarcoma viral oncogene homolog (KRAS) G12C mutations by reverse …

[HTML][HTML] Clinical features and outcomes of critically ill patients with coronavirus disease 2019 (COVID-19): A multicenter cohort study

KA Al Sulaiman, O Aljuhani, K Eljaaly… - International Journal of …, 2021 - Elsevier
Background Coronavirus disease-19 (COVID-19) manifested by a broad spectrum of symptoms,
ranging from asymptomatic manifestations to severe illness and death. The purpose of …

Evaluation of inhaled nitric oxide (iNO) treatment for moderate-to-severe ARDS in critically ill patients with COVID-19: a multicenter cohort study

K Al Sulaiman, GB Korayem, AF Altebainawi… - Critical Care, 2022 - Springer
Background Inhaled nitric oxide (iNO) is used as rescue therapy in patients with refractory
hypoxemia due to severe COVID-19 acute respiratory distress syndrome (ARDS) despite the …

The Impact of Recombinant Human Erythropoietin Administration in Critically ill COVID-19 Patients: A Multicenter Cohort Study

K Al Sulaiman, O Aljuhani… - Clinical and Applied …, 2023 - journals.sagepub.com
The use of erythropoietin-stimulating agents (ESAs) as adjunctive therapy in critically ill
patients with COVID-19 may have a potential benefit. This study aims to evaluate the effect of …

The predictors and risk factors of two-year rejection in renal transplant patients: A multicenter case-control study

…, HA Alhaidal, M Alghwainm, K Al Sulaiman - American Journal of …, 2024 - karger.com
… Alsulami and Khalid Al Sulaiman equally contributed to the conception and design of the
research. Nouf E AL-Otaibi, Hassan Almarhabi contributed to the acquisition and analysis of the …

Evaluation of Apixaban standard dosing in underweight patients with non-valvular atrial fibrillation: a retrospective cohort study

…, M Alfaifi, AF Alharthi, M Alzahrani, T Al Sulaiman… - Thrombosis …, 2024 - Springer
Background Recent guidelines recommend using direct oral anticoagulants (DOACs) as first-line
agents in patients with non-valvular atrial fibrillation (NVAF). Research is currently …

Profiling of pharmacogenomic variants in CYP2D6 and DPYD in indigenous Arab breast cancer patients

A Alsulaiman, H Chu, M Al-Jumaan, M Alyahya… - …, 2023 - Future Medicine
Aim: The indigenous Arab population is underrepresented in genomic studies and the
landscape of actionable pharmacogenomic variants among Arab breast cancer patients remains …

[PDF][PDF] Unusual Acute, Massive Lower Gastrointestinal Bleeding Secondary to a Proximal Jejunal Gastrointestinal Stromal Tumor: A Case Report

AA Alsulaiman, MN AlAli, MS Essa, O Alamri… - Cureus, 2023 - cureus.com
The most common primary non-epithelial neoplasms of the gastrointestinal (GI) tract are
gastrointestinal stromal tumors (GISTs). Ten percent (10%) of GISTs arise from the jejunum. …

A rare case of chondrosarcoma at the posterior costovertebral junction: a case report

…, A Alkheder, IA Al-Sulaiman - Annals of Medicine …, 2023 - journals.lww.com
Discussion: Chondrosarcoma is chemotherapy and radiotherapy-resistant. The total surgical
excision of the tumor with sufficient margins is usually curative. Conclusion: A follow-up is …